Status: Recruiting
Chronic Evaluation of Novel Pacemaker System
The primary study objective is to evaluate the feasibility, initial clinical safety and potential effectiveness of the Calyan Pacemaker system.
Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Calyan TechnologiesUpdated: Sep 1, 2026Locations: 1
Eligibility criteria
Age 18 or above [+3]
Patients with complete AV block or other pacemaker-dependent conditions [+24]